Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (121-130 of 233) with videos related to

Pageof 24
Sort By:
Therapeutic Advances in Medical Oncology|March 4, 2024
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysisFausto Petrelli, Maria Antista, Francesca Marra, et al.
Heliyon|September 12, 2024
First line therapy in stage IV BRAF mutated colorectal cancerFausto Petrelli, Maria Antista, Lorenzo Dottorini, et al.
F1000Research|August 2, 2022
Better survival of patients with oligo- compared with polymetastatic cancers:  a systematic review and meta-analysis of 173 studiesFausto Petrelli, Antonio Ghidini, Michele Ghidini, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancerAlberto Zaniboni, Andrea Ardizzoni, Filippo De Marinis, et al.
Cancer Medicine|March 19, 2026
Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer: A Systematic Review and Meta-AnalysisFausto Petrelli, Maria Antista, Antonio Ghidini, et al.
Breast Care (Basel, Switzerland)|March 21, 2014
Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine DifferentiationGiordano Savelli, Alberto Zaniboni, Francesco Bertagna, et al.
BMC Cancer|September 2, 2020
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018)Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo, et al.
International Journal of Colorectal Disease|March 29, 2020
A systematic review of salvage therapies in refractory metastatic colorectal cancerFausto Petrelli, Gianluca Perego, Antonio Ghidini, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 24, 2024
Perioperative safety and oncological efficacy of simultaneous versus colorectal and liver first two-staged resections in patients with synchronous colorectal liver metastases: a systematic review and network meta-analysisJasper P Sijberden, Maria S Alvarez Escribano, Meidai Kasai, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Pageof 24

Showing results (121-130 of 233) with videos related to

Sort By:
Pageof 24
Therapeutic Advances in Medical Oncology|March 4, 2024
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysisFausto Petrelli, Maria Antista, Francesca Marra, et al.
Heliyon|September 12, 2024
First line therapy in stage IV BRAF mutated colorectal cancerFausto Petrelli, Maria Antista, Lorenzo Dottorini, et al.
F1000Research|August 2, 2022
Better survival of patients with oligo- compared with polymetastatic cancers:  a systematic review and meta-analysis of 173 studiesFausto Petrelli, Antonio Ghidini, Michele Ghidini, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancerAlberto Zaniboni, Andrea Ardizzoni, Filippo De Marinis, et al.
Cancer Medicine|March 19, 2026
Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer: A Systematic Review and Meta-AnalysisFausto Petrelli, Maria Antista, Antonio Ghidini, et al.
Breast Care (Basel, Switzerland)|March 21, 2014
Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine DifferentiationGiordano Savelli, Alberto Zaniboni, Francesco Bertagna, et al.
BMC Cancer|September 2, 2020
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018)Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo, et al.
International Journal of Colorectal Disease|March 29, 2020
A systematic review of salvage therapies in refractory metastatic colorectal cancerFausto Petrelli, Gianluca Perego, Antonio Ghidini, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 24, 2024
Perioperative safety and oncological efficacy of simultaneous versus colorectal and liver first two-staged resections in patients with synchronous colorectal liver metastases: a systematic review and network meta-analysisJasper P Sijberden, Maria S Alvarez Escribano, Meidai Kasai, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Pageof 24